{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:31:02Z","timestamp":1777386662007,"version":"3.51.4"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2003,5]]},"abstract":"<jats:p>Approximately 10% of patients with hypertension have a high ratio of aldosterone to renin, but the reason for this and the relationships among low-renin essential hypertension, elevation of the ratio, and true primary aldosteronism are unclear. We have previously reported that a polymorphism of the gene (C-to-T conversion at position \u2212344) encoding aldosterone synthase is associated with hypertension, particularly in patients with a high ratio. However, the most consistent association with this variant is a relative impairment of adrenal 11\u03b2-hydroxylation. In this review, we propose that altered conversion of deoxycortisol to cortisol leads to a subtle, chronic increase in adrenocortrophin drive to the adrenal cortex, with eventual development of hyperplasia. In combination with other genetic or environmental factors (such as dietary sodium intake), we suggest that this might be responsible for the long-term development of a resetting of the aldosterone response to angiotensin II, giving rise to the phenotype of hypertension with a raised ratio. In some subjects, this may progress further to true primary aldosteronism with a dominant adrenal nodule. Thus, there may be a genetically influenced continuum from hypertension with a normal ratio, through hypertension with a raised ratio, and primary aldosteronism.<\/jats:p>","DOI":"10.1161\/01.hyp.0000064344.00173.44","type":"journal-article","created":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T20:28:48Z","timestamp":1051820928000},"page":"993-999","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":54,"title":["Is Altered Adrenal Steroid Biosynthesis a Key Intermediate Phenotype in Hypertension?"],"prefix":"10.1161","volume":"41","author":[{"given":"John M.C.","family":"Connell","sequence":"first","affiliation":[{"name":"From the MRC Blood Pressure Group, Division of Cardiovascular and Medical Sciences, University of Glasgow, Scotland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Fraser","sequence":"additional","affiliation":[{"name":"From the MRC Blood Pressure Group, Division of Cardiovascular and Medical Sciences, University of Glasgow, Scotland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"MacKenzie","sequence":"additional","affiliation":[{"name":"From the MRC Blood Pressure Group, Division of Cardiovascular and Medical Sciences, University of Glasgow, Scotland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor","family":"Davies","sequence":"additional","affiliation":[{"name":"From the MRC Blood Pressure Group, Division of Cardiovascular and Medical Sciences, University of Glasgow, Scotland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_1_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0493-346"},{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.9.3999"},{"key":"e_1_3_1_3_2","unstructured":"Loriaux DL McDonald WJ. Adrenal insufficiency. In: DeGroot LJ Jameson JL eds. Endocrinology. Philadelphia: WB Saunders Co; 2001: 1683\u20131690."},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.36.5.912"},{"key":"e_1_3_1_5_2","unstructured":"Gordon RD Stowasser M Klemm SA Tunny TJ. Primary aldosteronism and other forms of mineralocorticoid hypertension. In: Swales JD ed. Textbook of Hypertension. Oxford: Blackwell Scientific Publications; 1994: 865\u2013892."},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1993.tb01687.x"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1994.tb02519.x"},{"key":"e_1_3_1_8_2","first-page":"40.","volume":"353","year":"1999","unstructured":"Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM. Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet. 1999; 353: 40. Letter.","journal-title":"Lancet"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(02)00013-0"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1996.tb02059.x"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1996.tb02060.x"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)90424-4"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(84)90189-X"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-198308000-00014"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-198408000-00002"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0630257"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000013784.18175.51"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001321"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00070.x"},{"key":"e_1_3_1_20_2","first-page":"503","volume":"12","year":"1994","unstructured":"Jamieson A, Fraser R. Developments in the molecular biology of corticosteroid biosynthesis and action: implications for an understanding of essential hypertension. J Hypertens. 1994; 12: 503\u2013509.","journal-title":"J Hypertens"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)30030-4"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199407283310408"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/355262a0"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0880563"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.3109\/07435809509030459"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1677\/jme.0.0280125"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.33.2.703"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.34.3.423"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(98)00048-X"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.32.2.198"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.39.2.353"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2001-012070"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2001.01287.x"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.35.3.694"},{"key":"e_1_3_1_35_2","first-page":"1","volume":"54","year":"2000","unstructured":"Davies E, Holloway CD, Ingram MC, Friel EC, Inglis GC, Swan L, Hillis WS, Fraser R, Connell JM. An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ACTH in normal human subjects. Clin Endocrinol. 2000; 54: 1\u20136.","journal-title":"Clin Endocrinol"},{"key":"e_1_3_1_36_2","first-page":"194.","volume":"1","year":"2001","unstructured":"Kennon B, Ingram MC, Friel EC, Davies E, Fraser R, Connell JM. The \u2212T344C polymorphism of the aldosterone synthase gene influences urinary steroid excretion during dietary manipulation of the renin-angiotensin system. Endocr Abs. 2001; 1:P 194. Abstract.","journal-title":"Endocr Abs"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1998.00308.x"},{"key":"e_1_3_1_38_2","first-page":"613","volume":"7","year":"1985","unstructured":"de Simone G, Tommaselli AP, Rossi R, Valentino R, Lauria R, Scopacasa F, Lombardi G. Partial deficiency of adrenal 11\u03b2-hydroxylase: a possible cause of primary hypertension. Hypertension. 1985; 7: 613\u2013618.","journal-title":"Hypertension"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/07435809609043764"},{"key":"e_1_3_1_40_2","first-page":"2298","volume":"81","year":"1996","unstructured":"Jamieson A, Fraser R, Ingram MC, Connell JMC. Altered 11\u03b2-hydroxylase activity in glucocorticoid suppressible hyperaldosteronism. J Clin Endocrinol Metab. 1996; 81: 2298\u20132302.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_1_41_2","unstructured":"Symington T. The adrenal in hypertension. Functional Pathology of the Adrenal Gland. Edinburgh: E & S Livingstone Ltd; 2002: 79\u201380."},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1159\/000174773"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-9-3-295"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.1080091"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb03008.x"},{"key":"e_1_3_1_46_2","first-page":"61","volume":"96","year":"1981","unstructured":"Seifert C, Oelkers W. Aldosterone response to sodium deprivation and angiotensin II in patients with hypopituitarism. Acta Endocrinol. 1981; 96: 61\u201369.","journal-title":"Acta Endocrinol"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(99)00128-4"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-48-5-848"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-595X(72)80025-2"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002689900552"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.0000064344.00173.44","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T16:49:56Z","timestamp":1715532596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.0000064344.00173.44"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["10.1161\/01.HYP.0000064344.00173.44"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.0000064344.00173.44","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5]]},"assertion":[{"value":"2002-11-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-02-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-03-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}